Literature DB >> 9917966

Pulmonary toxicity of drugs used to treat systemic autoimmune diseases.

D Libby1, D A White.   

Abstract

A number of drugs used to treat systemic autoimmune diseases can cause respiratory complications. These include bronchospasm, noncardiac pulmonary edema, interstitial pneumonitis and fibrosis, hypersensitivity, and numerous other disorders. Additionally, some of these drugs increase the risk of infections, particularly with opportunistic organisms. This article reviews the clinical presentation and mechanism of toxicity of drug related pulmonary complications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9917966     DOI: 10.1016/s0272-5231(05)70118-0

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  3 in total

1.  A case of acute respiratory failure in a rheumatoid arthritis patient after the administration of abatacept.

Authors:  Birsen Doğu; Nurhan Atilla; Gözde Yıldırım Çetin; Nezir Yılmaz; Hafize Öksüz
Journal:  Eur J Rheumatol       Date:  2016-01-29

2.  Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma.

Authors:  Mark J Hamblin; Maureen R Horton
Journal:  Pulm Med       Date:  2011-06-04

3.  Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis.

Authors:  Tamao Nakashita; Katsutoshi Ando; Norihiro Kaneko; Kazuhisa Takahashi; Shinji Motojima
Journal:  BMJ Open       Date:  2014-08-14       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.